Encodia, a San Diego protein‑sequencing company that developed a DNA‑tagging peptide readout called ProteoCode, ceased operations and initiated an assignment for the benefit of creditors. The company, founded by veterans from Illumina and the next‑gen sequencing field, is auctioning lab equipment including mass spectrometers, sequencers, and liquid handlers. Encodia had raised $75 million in a 2021 Series C but closed late last year amid financial strain. The shutdown underscores the capital intensity and technical risk in early‑stage protein sequencing platforms and signals consolidation risks for niche enabling technologies in proteomics.